Search

Your search keyword '"DENIS, Y."' showing total 301 results

Search Constraints

Start Over You searched for: Author "DENIS, Y." Remove constraint Author: "DENIS, Y." Database Unpaywall Remove constraint Database: Unpaywall
301 results on '"DENIS, Y."'

Search Results

1. Digitalization in Remote Learning

2. Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response

3. Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins

4. New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses

6. Major role of S-glycoprotein in providing immunogenicity and protective immunity in mRNA lipid nanoparticle vaccines based on SARS-CoV-2 structural proteins

8. Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses

9. Antigenic Architecture of the H7N2 Influenza Virus Hemagglutinin Belonging to the North American Lineage

10. Synthesis and biological evaluation of fluoroquinolones containing a pyridoxine derivatives moiety

12. Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period

14. In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1

15. Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study

22. rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19

24. Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A

28. Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level

30. Free flaps to replace extensive and deep limb defects in children

35. Dynamics of SARS-CoV-2 Major Genetic Lineages in Moscow in the Context of Vaccine Prophylaxis

36. Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus

37. Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection

39. Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A

40. Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance

43. Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates

44. Antiviral Activity of N1,N3-Disubstituted Uracil Derivatives against SARS-CoV-2 Variants of Concern

48. Self-Timed Storage Register Cases

Catalog

Books, media, physical & digital resources